Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Steven P. Weitzman"'
Autor:
Trisha D. Cubb, Steven P. Weitzman
Publikováno v:
Clinical Thyroidology. 35:105-109
Autor:
Mark Zafereo, Chrysoula Dosiou, Giulia C. Kennedy, Yangyang Hao, Lori J. Wirth, Steven P. Weitzman, Joshua E. Babiarz, Richard T. Kloos, Mimi I. Hu, Syed Z. Ali, Peter M. Sadow, Brendan C. Stack, Jeffrey F. Krane, Steven G. Waguespack, Paul W. Ladenson, Masha J. Livhits
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 106:2198-2207
Context Broad genomic analyses among thyroid histologies have been described from relatively small cohorts. Objective Investigate the molecular findings across a large, real-world cohort of thyroid fine-needle aspiration (FNA) samples. Design Retrosp
Autor:
Mouhammed Amir Habra, Steven I. Sherman, Conor Best, Steven P. Weitzman, Neil D. Gross, Sarah B. Fisher, Ryan P. Goepfert, Camilo Jimenez, Anita K. Ying, Elizabeth G. Grubbs, Naifa L. Busaidy, Mark Zafereo, Maria E. Cabanillas, Steven G. Waguespack, Mimi I. Hu, Jennifer Wang, Paul H. Graham, Jeena Varghese, Erich M. Sturgis, Robert F. Gagel, Sonali Thosani, Nancy D. Perrier, Stephen Y. Lai, Ramona Dadu, Yelda Jozaghi
Publikováno v:
Head & Neck
Background In the face of the COVID‐19 pandemic, cancer care has had to adapt rapidly given the Centers for Disease Control and Prevention and the American College of Surgeons (ACS) issuing recommendations to postpone nonurgent surgeries. Methods A
Autor:
Mark Zafereo, Savitri Krishnamurthy, Steven P. Weitzman, Wei Wei, Jia Sun, Thinh Vu, J. Matthew Debnam, Naveen Garg, Salmaan Ahmed
Publikováno v:
Gland Surgery. 8:461-468
Background: The purpose of this study was to test the hypothesis that there is no significant difference in vascular flow patterns between cytopathologically-proven colloid nodules and papillary thyroid carcinoma (PTC) even when adjusting for nodule
Autor:
Steven P. Weitzman, Steven I. Sherman
Publikováno v:
Endocrinology and Metabolism Clinics of North America. 48:253-268
Systemic therapy options have emerged for treatment of progressive, radioiodine-refractory differentiated thyroid carcinoma. Approved therapies that target tumor angiogenesis, lenvatinib and sorafenib, improve progression-free survival and, in an old
Publikováno v:
Journal of the Endocrine Society
Background: Ectopic Cushing’s Syndrome is a rare but often aggressive condition caused by ACTH-hypersecretion from non-pituitary tumors. In patients with metastatic cancer, as well as those with occult tumors, the diagnosis and management can be ex
Autor:
Giulia C. Kennedy, Chrysoula Dosiou, Steven P. Weitzman, Joshua E. Babiarz, Richard T. Kloos, Yangyang Hao, Paul W. Ladenson, Lori J. Wirth, Elizabeth G. Grubbs, Masha J. Livhits, Steven I. Sherman
Publikováno v:
Journal of the Endocrine Society
Introduction: Receptor tyrosine kinases (RTKs) initiate signaling cascades, including growth and differentiation. Activation can occur through chromosomal rearrangements that lead to gene fusions. RTK fusions are potential targets for small molecule
Autor:
Joshua E. Babiarz, Syed Z. Ali, Lori J. Wirth, Jeffrey F. Krane, Steven P. Weitzman, Giulia C. Kennedy, Paul W. Ladenson, Mimi I. Hu, Mark Zafereo, Peter M. Sadow, Yangyang Hao, Brendan C. Stack, Steven G. Waguespack, Masha J. Livhits, Richard T. Kloos, Chrysoula Dosiou
Publikováno v:
Journal of Clinical Oncology. 39:6083-6083
6083 Background: Receptor tyrosine kinase (RTK) fusions may be targeted by small molecule inhibitors to treat various advanced tumors, including thyroid cancer. Clinical trials have studied selective inhibitors of ALK, BRAF, NTRK and RET, leading to
Autor:
Yeh Hung Yiin, Naifa L. Busaidy, William N. William, Stephen Y. Lai, Maria E. Cabanillas, Steven P. Weitzman, Laura Burke, Michelle D. Williams, Charles Lu, Anita K. Ying, G. Brandon Gunn
Publikováno v:
Head & Neck. 39:1291-1295
Background Anaplastic thyroid cancer (ATC) is a highly aggressive thyroid cancer. Several treatment trials are available, but the number of eligible patients to participate is very low because of the rarity and aggressiveness of the disease. Methods
Autor:
Steven P. Weitzman, Ramona Dadu, Denái R. Milton, Naifa L. Busaidy, Elizabeth G. Grubbs, Maria E. Cabanillas, Steven I. Sherman, William A. Murphy, Mimi I. Hu, Camilo Jimenez, Anita K. Ying, Mouhammed Amir Habra, Sarika N. Rao, Robert F. Gagel, Rena V. Sellin, Jian Yu Xu, Steven G. Waguespack
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 101:4871-4877
Bone metastases (BM) can lead to devastating skeletal-related events (SREs) in cancer patients. Data regarding medullary thyroid carcinoma (MTC) with BM are lacking.We evaluated the natural history of BM and SREs in MTC patients identified by a cance